Feed VRSEF
VR
Verisante Technology Inc. VRSEF OTC · Healthcare · Canada
$0.00 -4.76% -$0.00
Summary
42 / 100 · Bulios Score
Valuation 100Growth 0Profitability -Quality 79Debt 0Stability 4
What speaks for it
- It earns 127 CAD a year on every 100 CAD of invested capital.
- It has no debt and holds $4.71K in cash.
- You pay 1.7 CAD for 1 CAD of yearly profit, little for its sector.
What to watch
- Earnings per share fell by 79% a year over the last 3 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapP/E today 1.7
Medical - Devices industry median
Today you pay 1.7 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (CAD)
20212022202320242025
Diluted EPS (CAD)
20212022202320242025
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $4.71K
Debt $0.00
Free cash flow over 12 months -$31.3K
It has no debt. The debt score is low because of the debt-to-equity ratio.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.